|
Dr. Stephen B.H. Kent (age 62) has been a Director of the Company since January 2007. Dr. Kent is or has been a Professor of Biochemistry & Molecular Biology (2001-present) Professor of Chemistry (2002-present) and Director of the Institute for Biophysical Dynamics (2003-present) at the University of Chicago. Dr. Kent was the business founder and served as a director of Ciphergen Biosystems (1994-1997) and Gryphon Sciences (1994-2002). At Gryphon Sciences Kent served as President (1997-2000) CEO (1999-2000) and Chief Scientist (1997-2001). Dr. Kent has served on the Scientific Advisory Board at Amylin Pharmaceuticals from 2005 - present the Board of the Center for Functional Genomics Victoria University New Zealand from 2004 - present the Scientific Advisory Board Institute for Molecular Bioscience The University of Queensland Australia from 2001-present and the Scientific Advisory Board New York Blood Center & Kimball Research Institute from 1991-1997. Dr. Kent received Bachelor of Science and Master of Science degrees in his native New Zealand and his Ph.D. from the University of California Berkeley.
| 